| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 26, 2007
Accepted on September 17, 2007
From the Department of Pharmacology and Cancer Biology (C.M.F., C.D.K.), Duke University Medical Center and the Duke University School of Medicine (C.M.F.), Durham, NC; the Department of Medicine (C.M.F., C.D.K.), Division of Cardiovascular Medicine, Duke University Medical Center, Durham, NC; and the Department of Reproductive and Vascular Biology (M.J.C., A.A.), Institute for Biomedical Research, The Medical School, University of Birmingham, UK
* To whom correspondence should be addressed. E-mail: cdkontos{at}duke.edu.
Objective—Tie2 and its ligands, the angiopoietins (Ang), are required for embryonic and postnatal angiogenesis. Previous studies have demonstrated that Tie2 is proteolytically cleaved, resulting in the production of a 75-kDa soluble receptor fragment (sTie2). We investigated mechanisms responsible for Tie2 shedding and its effects on Tie2 signaling and endothelial cellular responses.
Methods and Results—sTie2 bound both Ang1 and Ang2 and inhibited angiopoietin-mediated Tie2 phosphorylation and antiapoptosis. In human umbilical vein endothelial cells, Tie2 shedding was both constitutive and induced by treatment with PMA or vascular endothelial growth factor (VEGF). Constitutive and VEGF-inducible Tie2 shedding were mediated by PI3K/Akt and p38 MAPK. Tie2 shedding was blocked by pharmacological inhibitors of either PI3K or Akt as well as by overexpression of the lipid phosphatase PTEN. In contrast, sTie2 shedding was enhanced by overexpression of either dominant negative PTEN, which increased Akt phosphorylation, or constitutively active, myristoylated Akt.
Conclusions—These findings demonstrate that VEGF regulates angiopoietin-Tie2 signaling by inducing proteolytic cleavage and shedding of Tie2 via a novel PI3K/Akt-dependent pathway. These results suggest a previously unrecognized mechanism by which VEGF may inhibit vascular stabilization to promote angiogenesis and vascular remodeling.
This article has been cited by other articles:
![]() |
M. van Meurs, N. F. Kurniati, F. M. Wulfert, S. A. Asgeirsdottir, I. A. de Graaf, S. C. Satchell, P. W. Mathieson, R. M. Jongman, P. Kumpers, J. G. Zijlstra, et al. Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function Am J Physiol Renal Physiol, August 1, 2009; 297(2): F272 - F281. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Morello, A. Perino, and E. Hirsch Phosphoinositide 3-kinase signalling in the vascular system Cardiovasc Res, May 1, 2009; 82(2): 261 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Swendeman, K. Mendelson, G. Weskamp, K. Horiuchi, U. Deutsch, P. Scherle, A. Hooper, S. Rafii, and C. P. Blobel VEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling Circ. Res., October 24, 2008; 103(9): 916 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Findley, R. G. Mitchell, B. D. Duscha, B. H. Annex, and C. D. Kontos Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease J. Am. Coll. Cardiol., July 29, 2008; 52(5): 387 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Cooke Critical Determinants of Limb Ischemia J. Am. Coll. Cardiol., July 29, 2008; 52(5): 394 - 396. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |